Companies that reported the most in general payments in 2022

Download CSV · 50 rows Free, no sign-in. Raw amounts in U.S. dollars; the second row says where the data came from.

• BioNTech SE 18.6% of the year $716,984,192 · 86 payments
• Pfizer Inc. 7% of the year $269,538,865 · 288,544 payments
• AbbVie, Inc. 3.7% of the year $143,914,703 · 1,546,790 payments
• Medtronic, Inc. 3.3% of the year $127,648,752 · 307,564 payments
• DePuy Synthes Products, Inc. 3.3% of the year $125,592,422 · 2,391 payments
• Stryker Corporation 2.9% of the year $112,985,817 · 140,786 payments
• Arthrex, Inc. 2.5% of the year $94,636,880 · 43,309 payments
• Smith+Nephew, Inc. 1.9% of the year $73,530,068 · 71,744 payments
• Zimmer Biomet Holdings, Inc. 1.7% of the year $67,075,419 · 31,602 payments
• Intuitive Surgical, Inc. 1.7% of the year $66,372,100 · 103,187 payments
• Boston Scientific Corporation 1.6% of the year $61,964,465 · 204,553 payments
• Genentech, Inc. 1.5% of the year $56,275,598 · 2,844 payments
• Takeda Pharmaceuticals U.S.A., Inc. 1.4% of the year $53,367,123 · 158,151 payments
• Allergan Inc. 1.3% of the year $51,337,330 · 135,555 payments
• AstraZeneca Pharmaceuticals LP 1.3% of the year $48,174,051 · 434,192 payments
• Genzyme Corporation 0.9% of the year $35,413,874 · 127,882 payments
• Triad Life Sciences Inc. 0.9% of the year $35,355,078 · 2,655 payments
• Lilly USA, LLC 0.9% of the year $34,618,208 · 401,374 payments
• Abbott Laboratories 0.9% of the year $34,336,136 · 311,817 payments
• Novo Nordisk Inc 0.9% of the year $33,939,339 · 522,321 payments
• E.R. Squibb & Sons, L.L.C. 0.8% of the year $30,765,476 · 158,770 payments
• Gilead Sciences, Inc. 0.8% of the year $30,671,043 · 91,073 payments
• GlaxoSmithKline, LLC. 0.7% of the year $28,647,303 · 338,636 payments
• Amgen Inc. 0.7% of the year $25,840,932 · 403,270 payments
• Janssen Pharmaceuticals, Inc 0.6% of the year $24,743,735 · 292,290 payments
• Incyte Corporation 0.6% of the year $22,062,823 · 67,539 payments
• AstraZeneca UK Limited 0.5% of the year $20,924,072 · 1,542 payments
• Encore Medical, LP 0.5% of the year $20,509,591 · 5,315 payments
• Bayer HealthCare Pharmaceuticals Inc. 0.5% of the year $20,377,032 · 205,338 payments
• Alcon Vision LLC 0.5% of the year $19,856,058 · 87,673 payments
• DePuy Synthes Sales Inc. 0.5% of the year $19,767,827 · 27,483 payments
• Medical Device Business Services, Inc. 0.5% of the year $19,504,050 · 21,872 payments
• CSL Behring 0.5% of the year $19,136,466 · 30,252 payments
• NuVasive, Inc. 0.5% of the year $18,969,014 · 12,992 payments
• Boehringer Ingelheim Pharmaceuticals, Inc. 0.5% of the year $17,825,027 · 238,115 payments
• Align Technology, Inc. 0.4% of the year $17,075,797 · 42,441 payments
• Merck Sharp & Dohme Corporation 0.4% of the year $16,943,245 · 226,930 payments
• Zimvie Inc. 0.4% of the year $16,359,418 · 44,228 payments
• Globus Medical, Inc. 0.4% of the year $16,238,644 · 12,374 payments
• Horizon Therapeutics plc 0.4% of the year $15,929,710 · 77,104 payments
• LivaNova USA, Inc. 0.4% of the year $15,755,537 · 7,572 payments
• Siemens Medical Solutions USA, Inc. 0.4% of the year $15,307,615 · 9,417 payments
• Regeneron Healthcare Solutions, Inc. 0.4% of the year $15,034,033 · 112,265 payments
• Edwards Lifesciences Corporation 0.4% of the year $14,673,602 · 50,580 payments
• Neurocrine Biosciences, Inc. 0.4% of the year $14,365,185 · 72,709 payments
• Linvatec Corporation 0.4% of the year $14,137,686 · 1,593 payments
• Alkermes, Inc. 0.4% of the year $13,737,849 · 88,138 payments
• Novartis Pharmaceuticals Corporation 0.4% of the year $13,585,942 · 392,791 payments
• Biohaven Pharmaceutical Holding Company Ltd. 0.4% of the year $13,396,313 · 220,446 payments
• Janssen Scientific Affairs, LLC 0.4% of the year $13,325,072 · 16,785 payments